Lataa...

Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir

Saquinavir, a potent human immunodeficiency virus protease inhibitor, is extensively metabolized by CYP3A4. Saquinavir is coadministered with ritonavir, a strong CYP3A4 inhibitor, to boost its exposure. Ketoconazole is a potent CYP3A inhibitor. The objectives of this study were to investigate the ef...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kaeser, Benoite, Zandt, Hagen, Bour, Fabrice, Zwanziger, Elke, Schmitt, Christophe, Zhang, Xiaoping
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2009
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630604/
https://ncbi.nlm.nih.gov/pubmed/19015329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00769-08
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!